PMID- 30304557 OWN - NLM STAT- MEDLINE DCOM- 20200619 LR - 20200619 IS - 1097-4644 (Electronic) IS - 0730-2312 (Linking) VI - 120 IP - 3 DP - 2019 Mar TI - Long noncoding RNA PVT1 promotes laryngeal squamous cell carcinoma development by acting as a molecular sponge to regulate miR-519d-3p. PG - 3911-3921 LID - 10.1002/jcb.27673 [doi] AB - OBJECTIVE: This study was designed to investigate the effects and mechanism of long noncoding RNA (lncRNA) PVT1 on cell migration, proliferation, and apoptosis of laryngeal squamous cell carcinoma (LSCC). METHODS: We screened lncRNAs expression profiles in four pair LSCC and matched noncancerous tissues by microarray assay. The messenger RNA levels of PVT1 in tissues and cells were evaluated by quantitative real-time polymerase chain reaction analysis. StarBase website was used to predict the target miRNAs for PVT1. And the interaction between PVT1 and target miRNA-519d-3p in LSCC cells was analyzed using dual-luciferase reporter assay. MTT assay was used to investigate the cell viability. Cell counting assay was used to explore the cell proliferation. Annexin-V propidium iodide flow cytometry was used to examine the cell apoptosis, and transwell assay was used to investigate the effects of lncRNA PVT1 on cell migration. RESULTS: PVT1 was significantly overexpressed in human LSCC tissues and several LSCC cell lines. Upregulation of lncRNA PVT1 markedly facilitated proliferation suppressed apoptosis and promoted cell migration in LSCC cells. We further demonstrated that silencing PVT1 strikingly suppressed proliferation, promoted apoptosis, and reduced migration in LSCC cells. Further bioinformatic analysis and dual-luciferase reporter assay revealed that PVT1 could function as an oncogenic transcript partly through sponging miR-519d-3p. Besides, mechanistic investigations indicated that PVT1 could promote cell and migration through interacting with miR-519d-3p. CONCLUSION: LncRNA PVT1 is consistently overexpressed in human LSCC, and overexpression of lncRNA PVT1 contributes to the proliferation and migration of LSCC through inhibiting miR-519d-3p expression. CI - (c) 2018 Wiley Periodicals, Inc. FAU - Zheng, Xiling AU - Zheng X AD - Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. FAU - Zhao, Kang AU - Zhao K AD - Department of Otorhinolaryngology Head and Neck Surgery, Xi'an Jiaotong University, Xi'an, Shaanxi, China. FAU - Liu, Tao AU - Liu T AD - Department of General Surgery, Yan'an University Affiliated Hospital, Yan'an, Shaanxi, China. FAU - Liu, Lei AU - Liu L AD - Department of General Surgery, Yan'an University Affiliated Hospital, Yan'an, Shaanxi, China. FAU - Zhou, Changming AU - Zhou C AD - Department of Otorhinolaryngology Head and Neck Surgery, Xi'an Jiaotong University, Xi'an, Shaanxi, China. FAU - Xu, Min AU - Xu M AUID- ORCID: 0000-0002-2923-5837 AD - Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20181010 PL - United States TA - J Cell Biochem JT - Journal of cellular biochemistry JID - 8205768 RN - 0 (Antagomirs) RN - 0 (MIRN519 microRNA, human) RN - 0 (MicroRNAs) RN - 0 (Oligoribonucleotides) RN - 0 (PVT1 long-non-coding RNA, human) RN - 0 (RNA, Long Noncoding) SB - IM MH - Antagomirs/genetics/metabolism MH - Apoptosis/genetics MH - Base Sequence MH - Carcinoma, Squamous Cell/*genetics/metabolism/pathology/surgery MH - Cell Line MH - Cell Line, Tumor MH - Cell Movement MH - Cell Proliferation MH - *Gene Expression Regulation, Neoplastic MH - Humans MH - Laryngeal Neoplasms/*genetics/metabolism/pathology/surgery MH - MicroRNAs/*genetics/metabolism MH - Neoplasm Invasiveness MH - Oligoribonucleotides/genetics/metabolism MH - RNA, Long Noncoding/agonists/antagonists & inhibitors/*genetics/metabolism MH - Signal Transduction OTO - NOTNLM OT - laryngeal squamous cell carcinoma OT - long noncoding RNA PVT1 OT - miR-519d-3p EDAT- 2018/10/12 06:00 MHDA- 2020/06/20 06:00 CRDT- 2018/10/11 06:00 PHST- 2018/05/04 00:00 [received] PHST- 2018/08/21 00:00 [accepted] PHST- 2018/10/12 06:00 [pubmed] PHST- 2020/06/20 06:00 [medline] PHST- 2018/10/11 06:00 [entrez] AID - 10.1002/jcb.27673 [doi] PST - ppublish SO - J Cell Biochem. 2019 Mar;120(3):3911-3921. doi: 10.1002/jcb.27673. Epub 2018 Oct 10.